# Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

> **NCT01432704** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Turku** · enrollment: 70 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** colecalciferol

## Key facts

- **NCT ID:** NCT01432704
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432704, "Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01432704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*